SpyGlass Pharma, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2024 | $-22.0M | $-24.0M | $2.0M | $1.5M |
| FY2025 | $-32.7M | $-33.5M | $789.0K | $2.8M |
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2024 | $-22.0M | $-24.0M | $2.0M | $1.5M |
| FY2025 | $-32.7M | $-33.5M | $789.0K | $2.8M |